Antimalarials: Pre-Clinical development update
Keywords:
Artemisin, Resistance, Malaria, Novel drugsAbstract
Diverse strategies exist for the development of novel antimalarials drug to tackle the increasing incidence of artemisin resistance. New molecules have been developed which hold a promise to cater to this unmet need. We discuss few drugs currently under pre-clinical development that have shown encouraging results.
Asian Journal of Medical Sciences Vol.8(5) 2017 1-3
Abstract
951
PDF
0
Downloads
Published
2017-08-31
How to Cite
Antimalarials: Pre-Clinical development update. (2017). Asian Journal of Medical Sciences, 8(5), 1-3. https://doi.org/10.3126/ajms.v8i5.17530
Issue
Section
Review Articles
License
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
Antimalarials: Pre-Clinical development update. (2017). Asian Journal of Medical Sciences, 8(5), 1-3. https://doi.org/10.3126/ajms.v8i5.17530
